Eastern Canadian Colorectal Cancer Consensus Conference: application of new modalities of staging and treatment of gastrointestinal cancers

T. Di Valentin, Y. Alam, A. Ali Alsharm, S. Arif, F. Aubin, J. Biagi, C.M. Booth, S. Bourque, R. Burkes, P. Champion, B. Colwell, C. Cripps, M. Dallaire, M. Dorreen, N. Finn, D. Frechette, S. Gallinger, J. Gapski, C. Giacomantonio, S. Gill, R. Goel, R. Goodwin, L. Grimard, A. Grothey, N. Hammad, D. Hedley, K. Jhaveri, D. Jonker, Y. Ko, M. L’Espérance, J. Maroun, H. Ostic, N. Perrin, M. Rother, E. St-Hilaire, M. Tehfe, M. Thirlwell, S. Welch, N. Yarom, T. Asmis

Abstract


The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Ottawa, Ontario, October 22–23, 2010. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer, such as the use of epidermal growth factor inhibitors in metastatic colon cancer, the benefit of calcium and magnesium with oxaliplatin chemotherapy, the role of microsatellites in treatment decisions for stage II colon cancer, the staging and treatment of rectal cancer, and the management of colorectal and metastatic pancreatic cancers.


Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.19.931






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)